BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2193443)

  • 1. A European multicenter study of chronic graft-versus-host disease. The role of cytomegalovirus serology in recipients and donors--acute graft-versus-host disease, and splenectomy.
    Boström L; Ringdén O; Jacobsen N; Zwaan F; Nilsson B
    Transplantation; 1990 Jun; 49(6):1100-5. PubMed ID: 2193443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant herpes virus serology and chronic graft-versus-host disease.
    Boström L; Ringdén O; Sundberg B; Ljungman P; Linde A; Nilsson B
    Bone Marrow Transplant; 1989 Sep; 4(5):547-52. PubMed ID: 2551436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretransplant herpesvirus serology and acute graft-versus-host disease.
    Boström L; Ringdén O; Sundberg B; Linde A; Tollemar J; Nilsson B
    Transplantation; 1988 Oct; 46(4):548-52. PubMed ID: 2845612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation.
    Boström L; Ringdén O; Gratama JW; Jacobsen N; Prentice HG; Zwaan FE; Nilsson B
    Bone Marrow Transplant; 1990 May; 5(5):321-6. PubMed ID: 2190659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Jacobsen N; Andersen HK; Skinhøj P; Ryder LP; Platz P; Jerne D; Faber V
    Scand J Haematol; 1986 May; 36(5):499-506. PubMed ID: 3016881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J; Ringdén O
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients.
    Hägglund H; Boström L; Remberger M; Ljungman P; Nilsson B; Ringdén O
    Bone Marrow Transplant; 1995 Dec; 16(6):747-53. PubMed ID: 8750264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation.
    Ochs LA; Miller WJ; Filipovich AH; Haake RJ; McGlave PB; Blazar BR; Ramsay NK; Kersey JH; Weisdorf DJ
    Bone Marrow Transplant; 1994 Apr; 13(4):455-60. PubMed ID: 8019471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
    Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
    Bone Marrow Transplant; 1998 Oct; 22(8):755-61. PubMed ID: 9827972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Bacigalupo A; Van Lint MT; Occhini D; Margiocco M; Ferrari G; Pittaluga PA; Frassoni F; Peralvo J; Lercari G; Carubia F
    Transplantation; 1988 Jun; 45(6):1091-4. PubMed ID: 3289150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensification of GVHD prophylaxis interferes with the effects of pretransplant herpes virus serology on the occurrence of grades II-IV acute graft-versus-host disease.
    Gratama JW; vd Nat H; Weiland HT; Stijnen T; Fibbe WE; Vossen JM; Willemze R; Verdonck LF
    Ann Hematol; 1992 Jun; 64 Suppl():A137-9. PubMed ID: 1322184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of pretransplant viral serology and complications of bone marrow transplantation.
    Ringdén O
    Ann Hematol; 1992 Jun; 64 Suppl():A143-7. PubMed ID: 1322186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of IgA deficiency after bone marrow transplantation. The influence of acute and chronic graft-versus-host disease.
    Abedi MR; Hammarström L; Ringdén O; Smith CI
    Transplantation; 1990 Sep; 50(3):415-21. PubMed ID: 2402790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation.
    Weisdorf D; Hakke R; Blazar B; Miller W; McGlave P; Ramsay N; Kersey J; Filipovich A
    Transplantation; 1991 Jun; 51(6):1197-203. PubMed ID: 2048196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation.
    Eisner MD; August CS
    Bone Marrow Transplant; 1995 May; 15(5):663-8. PubMed ID: 7670393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.
    Boström L; Ringdén O; Forsgren M
    Scand J Immunol; 1991 Jul; 34(1):45-52. PubMed ID: 1648786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of factors predisposing to chronic graft-versus-host disease.
    Ringdén O; Paulin T; Lönnqvist B; Nilsson B
    Exp Hematol; 1985 Nov; 13(10):1062-7. PubMed ID: 2996920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors.
    Gaziev D; Polchi P; Galimberti M; Angelucci E; Giardini C; Baronciani D; Erer B; Lucarelli G
    Transplantation; 1997 Mar; 63(6):854-60. PubMed ID: 9089226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.